Phase II Clinical Trial of Antigen pulsed dendritic cells (APDC) combined with chemotherapy in the treatment for metastatic colorectal cancer

Trial Profile

Phase II Clinical Trial of Antigen pulsed dendritic cells (APDC) combined with chemotherapy in the treatment for metastatic colorectal cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Colorectal cancer vaccine (Primary) ; Dendritic cells; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Actual end date (10 Jun 2008) added as reported by Chinese Clinical Trial Register record.
    • 21 Mar 2012 Status changed from recruiting to completed as reported by Chinese Clinical Trial Register.
    • 26 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top